Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Bitcoin Trust (IBIT) vs Medpace Holdings Inc (MEDP) Price & Performance

iShares Bitcoin TrustTrade
Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

iShares Bitcoin Trust vs Medpace Holdings Inc — how do they compare? iShares Bitcoin Trust trades at $36.15, while Medpace Holdings Inc trades at $601.69 (market cap $16.90B). The key difference: Medpace Holdings Inc is trading nearer its 52-week high, iShares Bitcoin Trust nearer its low. Which is the better fit depends on your goals.

IBITMEDP
Sector
Crypto-linkedTechnology
52-Week High
$71.29$620.59
52-Week Low
$33.29$393.42
Market Cap
$16.90B
Enterprise Value
$16.52B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Bitcoin Trust

IBIT trades at $36.24, showing minimal daily movement with a 0.01% gain. Technical indicators signal a bearish trend with moving averages in sell territory, though oscillators remain neutral. The stock faces resistance at $37 and finds support at $36. Recent news highlights institutional interest in crypto ETFs, with BlackRock's digital assets head noting 'overwhelming demand' (Bloomberg, August 10, 2026).

The outlook remains cautious due to bearish technical signals and Bitcoin's 50% decline from 2025 peaks. Long-term potential exists via institutional adoption, but near-term risks include crypto market volatility and selective ETF inflows. Investors should weigh technical weakness against BlackRock's growing ETF footprint.

Medpace Holdings Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About iShares Bitcoin Trust

IBIT is a spot Bitcoin ETF that tracks the price of Bitcoin directly. Managed by BlackRock, it offers investors a regulated way to gain exposure to the digital asset within a traditional brokerage account.

Read more on IBIT

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP